BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31673207)

  • 1. Conventional Fractionation versus Quad Shot in Advanced Head-and-Neck Cancers: A Randomized Controlled Trial.
    Choudhary A; Gupta A
    Indian J Palliat Care; 2019; 25(4):527-534. PubMed ID: 31673207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer.
    Corry J; Peters LJ; Costa ID; Milner AD; Fawns H; Rischin D; Porceddu S
    Radiother Oncol; 2005 Nov; 77(2):137-42. PubMed ID: 16260054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 "QUAD shot" regimen for incurable head and neck cancer.
    Toya R; Saito T; Yamaguchi K; Matsuyama T; Watakabe T; Matsumoto T; Yoshida R; Hirosue A; Murakami D; Orita Y; Nakayama H; Oya N
    Radiat Oncol; 2020 May; 15(1):123. PubMed ID: 32460865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: institutional experience and review of palliative regimens.
    Finnegan TS; Bhatt NH; Shaughnessy JN; Perez C; Redman R; Silverman C; Bumpous J; Potts K; Dunlap NE
    J Community Support Oncol; 2016 Jan; 14(1):29-36. PubMed ID: 26870840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot.
    Ma J; Lok BH; Zong J; Gutiontov SI; Cai X; Bell AC; Shcherba M; Xiao H; Sherman EJ; Tsai CJ; Riaz N; McBride SM; Cahlon O; Lee NY
    Int J Part Ther; 2018; 4(4):10-19. PubMed ID: 30246055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quad-shot-immunotherapy: quad-shot radiotherapy with pembrolizumab for advanced/recurrent head and neck cancer.
    Hughes RT; Gebeyehu RR; Kalada JM; Lycan TW; Frizzell BA; Kinney RD; D'Agostino RB; Bunch PM; Triozzi P; Zhang W; Furdui CM; Porosnicu M
    Future Oncol; 2023 Jul; 19(22):1523-1534. PubMed ID: 37199326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclical hypofractionated radiotherapy also known as "QUAD Shot" alone using intensity-modulated radiotherapy for squamous cell carcinoma of the parotid gland in an 85-year-old patient with multiple comorbidities.
    Kil WJ; Camphausen K
    Head Neck; 2017 Apr; 39(4):E55-E60. PubMed ID: 28170130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QUAD SHOT - an effective hypofractionated palliative radiotherapy in patients with non-melanoma skin cancer. A single-institution experience.
    Graczyk Ɓ; Bibik R; WoĆșniak A; JesieƄ-Lewandowicz E; Ciupis J; Szyburski M; Bajer J; ChaƂubiƄska-Fendler J; Fijuth J; JoƄska-Gmyrek JG
    Contemp Oncol (Pozn); 2023; 27(2):80-89. PubMed ID: 37794986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quad shot: a short but effective schedule for palliative radiation for head and neck carcinoma.
    Ghoshal S; Chakraborty S; Moudgil N; Kaur M; Patel FD
    Indian J Palliat Care; 2009 Jul; 15(2):137-40. PubMed ID: 20668593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated Palliative Radiotherapy with Concurrent Radiosensitizing Chemotherapy for Advanced Head and Neck Cancer Using the "QUAD-SHOT Regimen".
    Gamez ME; Agarwal M; Hu KS; Lukens JN; Harrison LB
    Anticancer Res; 2017 Feb; 37(2):685-691. PubMed ID: 28179317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated Radiotherapy for Palliation in Locally Advanced Head and Neck Cancer.
    Spartacus RK; Dana R; Rastogi K; Bhatnagar AR; Daga D; Gupta K
    Indian J Palliat Care; 2017; 23(3):313-316. PubMed ID: 28827937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Evaluation of Three Palliative Radiotherapy Schedules in Locally Advanced Head and Neck Cancer.
    Soni A; Kaushal V; Verma M; Dhull AK; Atri R; Dhankhar R
    World J Oncol; 2017 Feb; 8(1):7-14. PubMed ID: 28983378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated hypofractionation (OCTA SHOT): Palliative radiation schedule in advanced head and neck carcinoma.
    Jakhar SL; Purohit R; Solanki A; Murali P; Kothari T; Sharma N; Kumar HS
    J Cancer Res Ther; 2017; 13(6):943-946. PubMed ID: 29237955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.
    Fan D; Kang JJ; Fan M; Wang H; Lee A; Yu Y; Chen L; Jillian Tsai C; McBride SM; Riaz N; Gelblum DY; Neal BP; Fetten J; Dunn LA; Michel LS; Boyle JO; Cohen MA; Roman BR; Ganly I; Singh B; Wong RJ; Sherman EJ; Lee NY
    Oral Oncol; 2020 May; 104():104641. PubMed ID: 32182548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Did the Pandemic Teach Us About Palliative Radiation in Head and Neck Cancer?
    Ghoshal S; Singla AK; Ballari N; Gupta A
    J Palliat Care; 2022 Jul; 37(3):317-322. PubMed ID: 34866493
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypofractionated Palliative Radiotherapy in Locally Advanced Inoperable Head and Neck Cancer: CMC Vellore Experience.
    Das S; Thomas S; Pal SK; Isiah R; John S
    Indian J Palliat Care; 2013 May; 19(2):93-8. PubMed ID: 24049349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful Preoperative QUAD SHOT for Bulky Parotid Carcinoma: Potential Preoperative Ultra-Hypofractionated Radiotherapy for Conversion Surgery.
    Takahashi S; Endo M; Nagatomo T; Onaga R; Yamaguchi H; Yamamoto R; Fukuda Y; Ogawa K; Nakamura M; Okada K; Akahane K; Kawahara M; Nishino H; Kanazawa T; Mori H; Shirai K
    Case Rep Oncol; 2023; 16(1):218-226. PubMed ID: 37069898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice-weekly palliative radiotherapy for locally very advanced head and neck cancers.
    Murthy V; Kumar DP; Budrukkar A; Gupta T; Ghosh-Laskar S; Agarwal J
    Indian J Cancer; 2016; 53(1):138-41. PubMed ID: 27146764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers.
    Lok BH; Jiang G; Gutiontov S; Lanning RM; Sridhara S; Sherman EJ; Tsai CJ; McBride SM; Riaz N; Lee NY
    Oral Oncol; 2015 Oct; 51(10):957-62. PubMed ID: 26282714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.